Om Pharmaceuticals Limited loan details
Charges taken from banks & financial institutesData last updated:
Amount in (₹)
Om Pharmaceuticals Limited has 8 charges registered with the Registrar of Companies: 1 open charge worth Rs 4.00 M and 7 satisfied charges worth Rs 8.95 Cr. The most recent charge was created on 06 Sep 2024 for Rs 4.00 M and is open.
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
₹40.00 lakh
₹895.00 lakh
2
Others
Creation
06 Sep 2024
₹40.00 lakh
| Charge Id | Lender | Amount | Creation Date | Last Modification Date | Satisfaction Date | Status |
|---|---|---|---|---|---|---|
| 10050777 View Details | Others | ₹ 320.00 | 03 Apr 2007 | 22 Sep 2017 | 24 Mar 2024 | Satisfied |
| 10456602 View Details | Bank Of Maharashtra | ₹ 85.00 | 10 Oct 2013 | - | 11 Aug 2020 | Satisfied |
| 10317475 View Details | Bank Of Maharashtra | ₹ 110.00 | 03 Nov 2011 | - | 13 Sep 2017 | Satisfied |
| 10233504 View Details | Bank Of Maharashtra | ₹ 135.00 | 08 Jul 2010 | - | 03 May 2016 | Satisfied |
| 10050780 View Details | Bank Of Maharashtra | ₹ 135.00 | 03 Apr 2007 | - | 23 Aug 2014 | Satisfied |
| 90216294 View Details | Bank Of Maharashtra | ₹ 80.00 | 16 Aug 2000 | - | 26 Jul 2010 | Satisfied |
| 90218363 View Details | Bank Of Maharashtra | ₹ 30.00 | 04 Aug 2000 | - | 06 May 2010 | Satisfied |
| 100975176 View Details | Others | ₹ 40.00 | 06 Sep 2024 | - | - | Open |
Premium access Charge documents and asset detailsThe filed charge documents and the assets pledged under each charge are in the company report.
Verified entity values are shown only after access is granted. | ||||||
A charge is a security interest a company creates over its assets in favour of a lender. An open charge is still outstanding; a satisfied charge has been repaid and closed with the Registrar. Under the Companies Act, 2013 every charge must be registered within thirty days of creation (Form CHG-1, or CHG-9 for debentures) and its satisfaction reported within thirty days of repayment (Form CHG-4). Amounts are as filed with the MCA.